Tom is the former President of Glaxo and the former President and COO of Pharmaceutical Product Development (PPDI). Tom is active in National Association of Corporate Directors (NACD) affairs and has advised several biotech start-ups. He is currently on the board of Salix Pharmaceuticals (SLXP). |